MSB 0.69% $1.44 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-813

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 288 Posts.
    lightbulb Created with Sketch. 77
    For 2nd BLA refiling, 31 January 2023 update used the words "expected to be filed shortly"

    https://hotcopper.com.au/data/attachments/6214/6214899-7a06219b8ee86861fa38cdce9157ada6.jpg




    Literally the next day, 1 February 2023, we received a further update confirming BLA resubmission.

    https://hotcopper.com.au/data/attachments/6214/6214902-944ee92fd1499bb9a96963482c0145f8.jpg



    If SI said during BP conference that BLA submission is "imminent", I have a feeling it may be filed in the coming week.

    Once the FDA formally acknowledges receipt and assign classification (either class 1 or 2), we should get the PFUDA date.

    The clock for PFUDA date starts running from FDA's "receipt date", rather than the submission date.

    https://hotcopper.com.au/data/attachments/6214/6214903-6ea34376d0a254b19f6def9964128622.jpg

    We're almost there.

    GLTALTH!!!!!!!

    Last edited by Blackkkkkkk: 01/06/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.